BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38506205)

  • 21. CCR8 Signaling
    Kang L; Schmalzl A; Leupold T; Gonzalez-Acera M; Atreya R; Neurath MF; Becker C; Wirtz S
    Front Immunol; 2020; 11():609400. PubMed ID: 33613532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of CCR8(+) inflammatory myeloid cells in cancer patients with urothelial and renal carcinomas.
    Eruslanov E; Stoffs T; Kim WJ; Daurkin I; Gilbert SM; Su LM; Vieweg J; Daaka Y; Kusmartsev S
    Clin Cancer Res; 2013 Apr; 19(7):1670-80. PubMed ID: 23363815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice.
    Heymann F; Hammerich L; Storch D; Bartneck M; Huss S; Rüsseler V; Gassler N; Lira SA; Luedde T; Trautwein C; Tacke F
    Hepatology; 2012 Mar; 55(3):898-909. PubMed ID: 22031018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR8
    Barsheshet Y; Wildbaum G; Levy E; Vitenshtein A; Akinseye C; Griggs J; Lira SA; Karin N
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6086-6091. PubMed ID: 28533380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1
    Wang M; Qin Z; Wan J; Yan Y; Duan X; Yao X; Jiang Z; Li W; Qin Z
    Cancer Immunol Immunother; 2022 Nov; 71(11):2717-2730. PubMed ID: 35428909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.
    Goya I; Gutiérrez J; Varona R; Kremer L; Zaballos A; Márquez G
    J Immunol; 1998 Feb; 160(4):1975-81. PubMed ID: 9469461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR8 signaling influences Toll-like receptor 4 responses in human macrophages in inflammatory diseases.
    Reimer MK; Brange C; Rosendahl A
    Clin Vaccine Immunol; 2011 Dec; 18(12):2050-9. PubMed ID: 21976223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice.
    Vila-Caballer M; González-Granado JM; Zorita V; Abu Nabah YN; Silvestre-Roig C; Del Monte-Monge A; Molina-Sánchez P; Ait-Oufella H; Andrés-Manzano MJ; Sanz MJ; Weber C; Kremer L; Gutiérrez J; Mallat Z; Andrés V
    J Mol Cell Cardiol; 2019 Jul; 132():154-163. PubMed ID: 31121182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists.
    Liu L; Doijen J; D'huys T; Verhaegen Y; Dehaen W; De Jonghe S; Schols D; Van Loy T
    Biochem Pharmacol; 2021 Jun; 188():114565. PubMed ID: 33872569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4
    Liu S; Tao Z; Lou J; Li R; Fu X; Xu J; Wang T; Zhang L; Shang W; Mao Y; Wang F
    J Transl Med; 2023 Nov; 21(1):803. PubMed ID: 37950246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transient expression of C-C chemokine receptor 8 in thymus identifies a thymocyte subset committed to become CD4+ single-positive T cells.
    Kremer L; Carramolino L; Goya I; Zaballos A; Gutiérrez J; Moreno-Ortiz M del C; Martínez-A C; Márquez G
    J Immunol; 2001 Jan; 166(1):218-25. PubMed ID: 11123295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-184-5p represses neuropathic pain by regulating CCL1/CCR8 signaling interplay in the spinal cord in diabetic mice.
    Wu D; Zhong S; Du H; Han S; Wei X; Gong Q
    Neurol Res; 2024 Jan; 46(1):54-64. PubMed ID: 37842802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathic pain inhibitor, RAP-103, is a potent inhibitor of microglial CCL1/CCR8.
    Noda M; Tomonaga D; Kitazono K; Yoshioka Y; Liu J; Rousseau JP; Kinkead R; Ruff MR; Pert CB
    Neurochem Int; 2018 Oct; 119():184-189. PubMed ID: 29248693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel human CC chemokine receptor 8 (CCR8) antagonists via the synthesis of naphthalene amide and sulfonamide isosteres.
    Verhaegen Y; Liu L; Nguyen TT; Loy TV; Schols D; Voet ARD; Dehaen W; De Jonghe S
    Bioorg Chem; 2024 Apr; 145():107181. PubMed ID: 38354503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airways disease.
    Bishop B; Lloyd CM
    J Immunol; 2003 May; 170(9):4810-7. PubMed ID: 12707363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of CCR8, the receptor for the human CC chemokine I-309.
    Roos RS; Loetscher M; Legler DF; Clark-Lewis I; Baggiolini M; Moser B
    J Biol Chem; 1997 Jul; 272(28):17251-4. PubMed ID: 9211859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal CCL1/CCR8 regulates phosphorylation of GluA1-containing AMPA receptor in postoperative pain after tibial fracture and orthopedic surgery in mice.
    Wang C; Xu R; Wang X; Li Q; Li Y; Jiao Y; Zhao Q; Guo S; Su L; Yu Y; Yu Y
    Neurosci Res; 2020 May; 154():20-26. PubMed ID: 31121204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells.
    Iellem A; Colantonio L; Bhakta S; Sozzani S; Mantovani A; Sinigaglia F; D'Ambrosio D
    Eur J Immunol; 2000 Apr; 30(4):1030-9. PubMed ID: 10760790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of acupuncture and moxibustion at "Feishu""Dazhui"and "Fengmen"on the expression of CC chemokine ligand 1 and CC chemokine receptor 8 in lung tissue of rats with asthma].
    Hu XJ; Shao SJ; Hua JS; Wang PY; Zhang J; Ren Z; Xu N; Tian L
    Zhen Ci Yan Jiu; 2020 May; 45(5):363-7. PubMed ID: 32447849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.
    Sebastiani S; Allavena P; Albanesi C; Nasorri F; Bianchi G; Traidl C; Sozzani S; Girolomoni G; Cavani A
    J Immunol; 2001 Jan; 166(2):996-1002. PubMed ID: 11145678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.